Related references
Note: Only part of the references are listed.The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
Maria J. Garcia et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
Tuomas Heikkinen et al.
CLINICAL CANCER RESEARCH (2009)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
Marc D. Tischkowitz et al.
GASTROENTEROLOGY (2009)
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Shirley M. -H. Sy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
Anna Potapova et al.
CANCER RESEARCH (2008)
The Fanconi anemia pathway and ubiquitin
Celine Jacquemont et al.
BMC BIOCHEMISTRY (2007)
Analysis of PALB2/FANCN-associated breast cancer families
Marc Tischkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko et al.
NATURE (2007)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
William D. Foulkes et al.
BREAST CANCER RESEARCH (2007)
PTEN mutation, expression and LOH at its locus in ovarian carcinomas.: Relation to TP53, K-RAS and BRCA1 mutations
I. K. Kolasa et al.
GYNECOLOGIC ONCOLOGY (2006)
Geographical variations in TP53 mutational spectrum in ovarian carcinomas
A. Dansonka-Mieszkowska et al.
ANNALS OF HUMAN GENETICS (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Molecular pathogenesis of Fanconi anemia: recent progress
Toshiyasu Taniguchi et al.
BLOOD (2006)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
